Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Kelsen

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapyB D Minsky, A M Cohen, N Kemeny, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 1993
Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancerB D Minsky, A M Cohen, N Kemeny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumorsM N Fornier, D Rathkopf, M Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Pain and depression in patients with newly diagnosed pancreas cancerD P Kelsen, R K Portenoy, H T Thaler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecanS Sharma, N Kemeny, D P Kelsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagusD H Ilson, J Ajani, K Bhalla, et al.
American Journal of Clinical Oncology|October 1, 1985
Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancerM G Kris, R J Gralla, D P Kelsen, et al.
Chest|March 1, 1985
Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatmentM G Kris, R J Gralla, D P Kelsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2006
A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancerB Brenner, M A Shah, M S Karpeh, et al.
Journal of the National Cancer Institute|September 20, 1995
Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cellsG K Schwartz, A Haimovitz-Friedman, S K Dhupar, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapyB D Minsky, A M Cohen, N Kemeny, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 1993
Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancerB D Minsky, A M Cohen, N Kemeny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumorsM N Fornier, D Rathkopf, M Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Pain and depression in patients with newly diagnosed pancreas cancerD P Kelsen, R K Portenoy, H T Thaler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecanS Sharma, N Kemeny, D P Kelsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagusD H Ilson, J Ajani, K Bhalla, et al.
American Journal of Clinical Oncology|October 1, 1985
Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancerM G Kris, R J Gralla, D P Kelsen, et al.
Chest|March 1, 1985
Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatmentM G Kris, R J Gralla, D P Kelsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2006
A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancerB Brenner, M A Shah, M S Karpeh, et al.
Journal of the National Cancer Institute|September 20, 1995
Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cellsG K Schwartz, A Haimovitz-Friedman, S K Dhupar, et al.
Pageof 13